About

Provided by FenXun Partners

We regularly represent buyers, target companies, controlling shareholders, management, lenders and institutional investors in merger and acquisition projects involving listed and private companies, including state-owned enterprises.


We have profound understanding of the regulations and legal practice in China. We have also maintained close working relationships with the China Securities Regulatory Commission (CSRC), Ministry of Commerce (MOC), China Banking Regulatory Commission (CBRC), China Insurance Regulatory Commission (CIRC) and other regulatory bodies through project cooperation and consulting work. Our efforts ensure that we can provide precise legal advice and creative solutions to clients in M&A projects of various kinds. Specifically, we advise on public company privatization, tender offers, leveraged buyouts, negotiated acquisitions and divestitures, NPA acquisitions, spin-offs and other relevant issues.


In addition to M&A deals in non-financial sectors, we also represent foreign and foreign- invested financial institutions (including banks, insurance companies, security companies, and asset management companies) in investments and financing projects, as well as in establishing joint ventures and sole proprietorships in China.

Chambers Review

Provided by Chambers

Corporate/M&A (PRC Firms) - China

3
Band 3

What the Team is Known For

FenXun Partners has a proven track record in the market for its handling of complex inbound and outbound M&A projects. It routinely advises multinationals on the corporate law aspects of their business operations in China, including companies from the chemical and mechanical engineering sectors. The firm is part of a joint operation with Baker McKenzie, which affords it access to a global network of offices and expertise.

业务优势

奋迅律师事务所在处理复杂的境内外并购项目方面拥有良好的市场业绩。该所经常为跨国公司(包括化学和机械工程行业的公司)在中国业务运营的公司法方面提供咨询。该所是与贝克·麦坚时联营的一部分,使其能够利用全球办事处网络和专业知识。

Work Highlights

Provided by FenXun Partners

  • FenXun Partners advised GSK on its exclusive strategic partnership with Chongqing Zhifei Biological Products to promote GSK’s shingles vaccine Shingrix.

  • 奋迅律师事务所为葛兰素史克就其与重庆智飞生物建立独家战略合作伙伴关系提供法律服务,该合作以推广葛兰素史克的带状疱疹疫苗 Shingrix疫苗。

Strengths

Provided by Chambers

Notable Practitioners

Provided by Chambers

Hong Zhang
5
Hong Zhang
5
Band 5

Zhang Hong's solid knowledge makes her the linchpin in a wide variety of corporate/M&A transactions. Dual-qualified in New York and the PRC, she is frequently sought after by clients to deal with cross-border investments, joint ventures and strategic cooperation.

张宏律师扎实的知识使她成为各种企业并购交易的关键。她拥有纽约州和中国的双重执业资格,经常受到客户的追捧以处理跨境投资、合资企业和战略合作事宜。

Ranked Lawyers at
FenXun Partners

Provided by Chambers
Filter by
Band

China

Corporate/M&A (PRC Firms)

Hong Zhang
5
Hong Zhang
5
Band 5

Members

Provided by FenXun Partners

Cherrie Shi

Head of Department

Jacky Zhu

Jeff Xu

Kelly Han

Lei Ye

Leo Zhang

Richard Gao

Clients

Provided by FenXun Partners

ArcelorMittal

Chery

Guangzhou Tinci

Haier

Jinjiang International

Mondelez